Clinical trial · Interventional
Patient Navigation in Cancer Survivorship at a Safety Net Institution
Patient Navigation as Part of the Cancer Survivorship Care Plan at a Safety Net Institution
NCT03271099CI-TRIAL-00053763completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study seeks to enroll patients receiving a Survivorship Care Plan following curative therapy for cancer. Participants will be randomly assigned to receive usual care or to be followed by a Patient Navigator as part of their Survivorship Care Plan.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Navigator | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Usual Care
- description
- Usual care
- type
- EXPERIMENTAL
- label
- Navigator
- description
- Patient navigator services provided as part of survivorship care plan
- interventionNames
- Other: Navigator
Primary outcomes (1)
- measure
- Missed appointments
- timeFrame
- 9 months
- description
- The research team will document the number of cancer care appointments scheduled and of those, how many appointments were missed (obtained by medical record and by patient report in case a visit was outside of study institution).
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Stage I, II, III or IVa Cancer diagnosis (may include Solitary plasmacytoma, Diffuse Large B-Cell Lymphoma (DLBCL), ductal carcinoma in situ (DCIS) of the breast) * Completed treatment with curative intent within the past 12 months. (May be on maintenance therapy.) Exclusion Criteria: * Distant Metastatic disease * Non-curable disease * Recurrence of disease prior to enrollment * Require ongoing navigation from the treatment navigator * Enrolled/active in another randomized study (Project SUPPORT)
References
Publications (0)
Data not yet available
No reference posted for this study.